These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31914533)
1. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance]. Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533 [No Abstract] [Full Text] [Related]
2. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940 [TBL] [Abstract][Full Text] [Related]
4. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance]. Jing CX; Feng Y; Cao X; Xu CG Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142 [TBL] [Abstract][Full Text] [Related]
5. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases]. Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584 [No Abstract] [Full Text] [Related]
7. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma. He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407 [TBL] [Abstract][Full Text] [Related]
8. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples. Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830 [TBL] [Abstract][Full Text] [Related]
9. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857 [TBL] [Abstract][Full Text] [Related]
10. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745 [TBL] [Abstract][Full Text] [Related]
11. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas. Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma]. Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018 [No Abstract] [Full Text] [Related]
13. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas. Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898 [TBL] [Abstract][Full Text] [Related]
14. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma. He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825 [TBL] [Abstract][Full Text] [Related]
15. Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders. Nakashima MO; Durkin L; Bodo J; Lin J; Quintanilla-Martinez L; Fu K; Hsi ED Appl Immunohistochem Mol Morphol; 2014; 22(10):720-7. PubMed ID: 25229384 [TBL] [Abstract][Full Text] [Related]
16. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance]. Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417 [TBL] [Abstract][Full Text] [Related]
17. SOX11, a key oncogenic factor in mantle cell lymphoma. Beekman R; Amador V; Campo E Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568 [TBL] [Abstract][Full Text] [Related]
19. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B Sci Rep; 2013; 3():1400. PubMed ID: 23466598 [TBL] [Abstract][Full Text] [Related]
20. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]